trending Market Intelligence /marketintelligence/en/news-insights/trending/wrgh9cm8td6no2e55l1x5q2 content esgSubNav
In This List

Aradigm adds ContraVir Pharmaceuticals COO to board

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Aradigm adds ContraVir Pharmaceuticals COO to board

Aradigm Corp. said July 6 that Theresa Matkovits was added to its board.

Matkovits is with ContraVir Pharmaceuticals Inc., where she has been COO since December 2017. Prior to her COO role, she was ContraVir's executive vice president and head of drug development.

Hayward, Calif.-based Aradigm is a specialty pharmaceutical company that develops and commercializes medicines to prevent and treat severe respiratory diseases.